The REbif® vs Glatiramer Acetate in Relapsing Multiple Sclerosis Pharmacogenetics Trial

Clinical trial NCT01034579 · COMPLETED

Trial details

NCT number: NCT01034579
Sponsor: EMD Serono
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Relapsing Multiple Sclerosis

Start date: 2010-02-01
Primary completion: 2010-11-01
Enrollment: 324

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.